Innovations in Drug-Loaded Contact Lenses
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 373
Special Issue Editors
Interests: ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery systems; ocular drug delivery; ocular pharmacokinetic; drug development; cyclodextrins; nanotechnology
Special Issue Information
Dear Colleagues,
Topical ophthalmic administration is the preferred route for treating ophthalmic diseases. However, due to the complexity of the structure of the eye and its defense mechanisms, the bioavailability of topical ophthalmic drugs is significantly low.
Drug-loaded contact lenses are an interesting resource to improve ocular bioavailability as they allow the prolonged release of the drug from the lens to the tear film by increasing the retention time on the ocular surface. The main disadvantage of drug-loaded contact lenses is the low affinity of some drugs that implies a low charge capacity and rapid drug release. Alternatives to improve their behavior are being studied.
The aim of this Special Issue is to compile information on recent advances in the development, processing, and characterization of drug-loaded contact lenses.
Prof. Dr. Francisco Javier Otero-Espinar
Dr. Victoria Díaz-Tomé
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- contact lenses
- ocular drug delivery
- ophthalmic diseases
- therapeutic contact lens
- advanced ocular drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
